<?xml version='1.0' encoding='UTF-8' ?>
<html id="data-uuid-e128db7a06f34e978c77998069b42276" data-uuid="e128db7a06f34e978c77998069b42276" xmlns="http://www.w3.org/1999/xhtml">
    <head>
        <title>20.1 Cancer Cells</title>
        <meta charset="utf-8" />
        <link type="text/css" rel="stylesheet" media="screen" href="../../assets/css/main.css" />
    <link type="text/css" rel="stylesheet" href="../../assets/fonts/fonts.css" /><link type="text/css" rel="stylesheet" href="../../assets/css/epub_main.css" /><script src="../../assets/js/habitat_platform.js"></script></head>
    <body class="chapter20 card-chapter-reader">
        <header id="data-uuid-e053c67b832741239feae4787b757fe8" data-uuid="e053c67b832741239feae4787b757fe8">
            <h1 id="data-uuid-b0c0f17359544d73b87e1817e00e69b2" data-uuid="b0c0f17359544d73b87e1817e00e69b2"><span class="enum">20.1</span> Cancer Cells</h1>
        </header>
        <section id="data-uuid-e79f493eac1e4d43b52e98bc2949f014" data-uuid="e79f493eac1e4d43b52e98bc2949f014" class="sidenote sidenote-learning">
            <h4 id="data-uuid-fba187f5741b42268c582fa8ac9eea1e" data-uuid="fba187f5741b42268c582fa8ac9eea1e">LEARNING OUTCOMES</h4>
            <p id="data-uuid-2af5d705dfd44ba1a6d35ede84fa7fe3" data-uuid="2af5d705dfd44ba1a6d35ede84fa7fe3">Upon completion of this section, you should be able to</p>
            <ol id="data-uuid-92865af5ef7744c28a0ab32eb08e993b" data-uuid="92865af5ef7744c28a0ab32eb08e993b" class="list-bold">
                <li id="data-uuid-63b71eec13704e828cc94148efc82229" data-uuid="63b71eec13704e828cc94148efc82229">
                    <p id="data-uuid-43ddea56eb2346c09013bc295121ccd4" data-uuid="43ddea56eb2346c09013bc295121ccd4"> Describe the characteristics of cancer cells that distinguish them from normal cells.</p>
                </li>
                <li id="data-uuid-2efa43f83a0440dca94aee1362b1190e" data-uuid="2efa43f83a0440dca94aee1362b1190e">
                    <p id="data-uuid-0dce44056e544193b476e2db5f4ee310" data-uuid="0dce44056e544193b476e2db5f4ee310"> Distinguish between a proto-oncogene and a tumor suppressor gene with regard to their effects on the cell cycle.</p>
                </li>
                <li id="data-uuid-3d0e2f2fa6a84532acb4e458649d69ab" data-uuid="3d0e2f2fa6a84532acb4e458649d69ab">
                    <p id="data-uuid-5df175ff9f6648b4bdc790c99cd4ce0f" data-uuid="5df175ff9f6648b4bdc790c99cd4ce0f"> Identify the common types of cancers and the body system with which each is associated.</p>
                </li>
            </ol>
        </section>
        <p id="data-uuid-3c99454c02ca4940ad1e5ecdc3b2c56a" data-uuid="3c99454c02ca4940ad1e5ecdc3b2c56a"><a href="../glossary.xhtml#key-cancer"><dfn title="cancer">Cancer</dfn></a> is disease characterized by uncontrolled cell growth. Although there are many different types of cancer, and the causes vary widely, most cancers are a result of a cell accumulating mutations that ultimately cause a loss of control over the cell cycle.</p>
        <h2 id="data-uuid-92a0499e745a40b599a932f80fa33c0a" data-uuid="92a0499e745a40b599a932f80fa33c0a">Characteristics of Cancer Cells</h2>
        <p id="data-uuid-b2ca074de42c4dbfb8e87ec06952db5f" data-uuid="b2ca074de42c4dbfb8e87ec06952db5f">While the effects of cancer are often noticed at the tissue, organ, or organismal level, cancer is ultimately a cellular disease. Despite the large number of different cancer types, cancer cells share general traits that distinguish them from normal cells.</p>
        <h3 id="data-uuid-6bffcfbc962e4b4d9cac7ec81ee6a542" data-uuid="6bffcfbc962e4b4d9cac7ec81ee6a542">Cancer Cells Lack Differentiation</h3>
        <p id="data-uuid-e3fb38c7aaca4dafbfc29a21670fc894" data-uuid="e3fb38c7aaca4dafbfc29a21670fc894"><a href="../glossary.xhtml#key-differentiation"><dfn title="differentiation">Differentiation</dfn></a> is the process of cellular development by which a cell acquires a specific structure and function. Red blood cells are examples of differentiated cells in the circulatory system. In comparison, cancer cells are nonspecialized and do not contribute to the functioning of a body part. A cancer cell does not look like a differentiated epithelial, muscle, nervous, or connective tissue cell. Instead, it looks distinctly abnormal.</p>
        <h3 id="data-uuid-61a924688e124430b719d3ee4b854f30" data-uuid="61a924688e124430b719d3ee4b854f30">Cancer Cells Have Abnormal Nuclei</h3>
        <p id="data-uuid-24e078c538884072a25b8720fe4ae53e" data-uuid="24e078c538884072a25b8720fe4ae53e">In <a href="ch20_reader_1.xhtml#data-uuid-a11e44df12b446ed9650f1aa251c7167" class="link-inline">Figure 20.1</a>, you can compare the appearance of normal cervical cells (<i>a</i>) with that of precancerous (<i>b</i>) and cancerous (<i>c</i>) cervical cells. The nuclei of cancer cells are enlarged and may contain an abnormal number of chromosomes. The nuclei of the cervical cancer cells (<a href="ch20_reader_1.xhtml#data-uuid-a11e44df12b446ed9650f1aa251c7167" class="link-inline">Fig. 20.1<i>c</i></a>) have increased to the point that they take up most of the cell.</p>
        <figure id="data-uuid-a11e44df12b446ed9650f1aa251c7167" data-uuid="a11e44df12b446ed9650f1aa251c7167">
            <img src="../../img/chapter20/ch20_figure_text_01.png" id="data-uuid-dfd26aea54fd4379a6fd6aee4dddbb67" data-uuid="dfd26aea54fd4379a6fd6aee4dddbb67" class="text-image ch20_figure_text_01" alt="" />
            <figcaption>
                <span class="figure-number">
                    <span class="figure-designation">Figure</span>
                    <span class="figure-enumeration">20.1</span>
                </span>
                <span class="caption-title">A comparison of normal tissue cells and cancer cells.</span>
                <span class="caption-body"><b>a.</b> Normal cervical cells. <b>b.</b> Precancerous cervical cells. <b>c.</b> Cancerous cervical cells.</span>
            </figcaption>
        </figure>
        <p id="data-uuid-ded0c8dd28564a25ab5f246e52a2d5d3" data-uuid="ded0c8dd28564a25ab5f246e52a2d5d3">In addition to nuclear abnormalities, cancer cells have defective chromosomes. Some portions of the chromosomes may be duplicated, and/or some may be deleted. In addition, gene amplification (extra copies of specific genes) is seen much more frequently than in normal cells. Ordinarily, cells with damaged DNA undergo <a href="../glossary.xhtml#key-apoptosis"><dfn title="apoptosis">apoptosis</dfn></a><b>,</b> or programmed cell death. Cancer cells fail to undergo apoptosis, even though they are abnormal cells.</p>
        <p id="data-uuid-ee3ec762738c4b339b275a2924ea529a" data-uuid="ee3ec762738c4b339b275a2924ea529a">Tissues that divide frequently, such as those that line the respiratory and digestive tracts, are more likely to become cancerous. Cell division gives them the opportunity to undergo genetic mutations, each one making the cell more abnormal and giving it the ability to produce more of its own type.</p>
        <h3 id="data-uuid-d38d97bce9a74280aa6993149c92193d" data-uuid="d38d97bce9a74280aa6993149c92193d">Cancer Cells Have Unlimited Potential to Replicate</h3>
        <p id="data-uuid-7c0f2a60269e417fbf8d4813859f0b01" data-uuid="7c0f2a60269e417fbf8d4813859f0b01">Ordinarily, cells divide about 60 to 70 times and then just stop dividing and eventually undergo apoptosis. Cancer cells are immortal and keep on dividing for an unlimited number of times.</p>
        <figure id="data-uuid-b0ee345927ad4b1a8caf57a2dec05a73" data-uuid="b0ee345927ad4b1a8caf57a2dec05a73" class="right-icon">
            <img src="../../img/chapter20/ch20_icon01.png" id="data-uuid-ab6daa6992404c879bf506174140dd9e" data-uuid="ab6daa6992404c879bf506174140dd9e" />
        </figure>
        <p id="data-uuid-7f539b8eadc74c4db754e663d0a8ff2f" data-uuid="7f539b8eadc74c4db754e663d0a8ff2f">Just as shoelaces are capped by small pieces of plastic, chromosomes in human cells end with special repetitive DNA sequences called <a href="../glossary.xhtml#key-telomere"><dfn title="telomere">telomeres</dfn></a><b>.</b> Specific proteins bind to telomeres in both normal and cancerous cells. These telomere proteins protect the ends of chromosomes from DNA repair enzymes. Though the enzymes effectively repair DNA in the center of the chromosome, they always tend to bind together the naked ends of chromosomes. In a normal cell, the telomeres get shorter after each cell cycle and protective telomere proteins gradually decrease. In turn, repair enzymes eventually cause the chromosomes’ ends to bind together, causing the cell to undergo apoptosis. Telomerase is an enzyme that can rebuild telomere sequences and in that way prevent a cell from ever losing its potential to divide. The gene that codes for telomerase is constantly turned on in cancer cells, and telomeres are continuously rebuilt. The telomeres remain at a constant length, and the cell can keep dividing over and over.</p>
        <section id="data-uuid-04d143e1c7324f77b9c3ff06e47c2b47" data-uuid="04d143e1c7324f77b9c3ff06e47c2b47" class="sidenote sidenote-application">
            <h4 id="data-uuid-8fd3f1c49da242cebdd97960da92b0a3" data-uuid="8fd3f1c49da242cebdd97960da92b0a3">Science in Your Life</h4>
            <h5 id="data-uuid-5ec29cb0114d43fb97335f1ccb0b9129" data-uuid="5ec29cb0114d43fb97335f1ccb0b9129">What’s the difference between a benign tumor and a malignant tumor?</h5>
            <p id="data-uuid-5cacbcf4857e41769a50eb0e589cea19" data-uuid="5cacbcf4857e41769a50eb0e589cea19">A <i>benign</i> tumor is usually surrounded by a connective tissue capsule. A benign tumor does not invade adjacent tissue because of the capsule. The cells of a benign tumor resemble normal cells fairly closely. Chances are you have one of these tumors. If you have a mole, or nevus, on your body, you have a benign tumor of the skin melanocytes. Cells from a mole closely resemble other melanocytes.</p>
            <figure id="data-uuid-0a0aeb7a633c49169983acc6eb939e9e" data-uuid="0a0aeb7a633c49169983acc6eb939e9e">
                <img src="../../img/chapter20/ch20_un_figure_02.png" id="data-uuid-0506e77c68da4141b6f23dafb3da2b96" data-uuid="0506e77c68da4141b6f23dafb3da2b96" class="text-image ch20_un_figure_02" alt="" />
            </figure>
            <p id="data-uuid-e52a433b21464db4b90f4952ea72fb97" data-uuid="e52a433b21464db4b90f4952ea72fb97">     However, despite the term <i>benign</i>, this type of tumor isn’t necessarily harmless. If it presses on normal tissue or restricts the normal tissue’s blood supply, a benign tumor can be fatal. For example, a benign neuroma (nerve cell tumor) growing near the brain stem eventually affects control centers for heartbeat and respiration.</p>
            <p id="data-uuid-6fb83c2a5708478b92611f79f351e13f" data-uuid="6fb83c2a5708478b92611f79f351e13f">On the other hand, a malignant tumor is able to invade surrounding tissues and its cells don’t resemble normal cells. By traveling in blood or lymphatic vessels, the tumor can spread throughout the body. As a general rule, badly deformed cells are most likely to spread. Thus, they are the most malignant.</p>
            <p id="data-uuid-b48c250bb47a4af8b263016acadb0f2a" data-uuid="b48c250bb47a4af8b263016acadb0f2a">Cancer in situ (in place) is a malignant tumor found in its place of origin. As yet, the cancer has not spread beyond the basement membrane, the nonliving material that anchors tissues to one another. If recognized and treated early, cancer in situ is usually curable.</p>
        </section>
        <h3 id="data-uuid-b6998c6333d240dbaec1cf11d9907425" data-uuid="b6998c6333d240dbaec1cf11d9907425">Cancer Cells Form Tumors</h3>
        <p id="data-uuid-d3cc859025d64ede8c78ca6055406413" data-uuid="d3cc859025d64ede8c78ca6055406413">Normal cells anchor themselves to a substratum and/or adhere to their neighbors. They exhibit <i>contact inhibition,</i> meaning that when they come in contact with a neighbor, they stop dividing. Cancer cells have lost all restraint. They pile on top of one another and grow in multiple layers, forming a <a href="../glossary.xhtml#key-tumor"><dfn title="tumor">tumor</dfn></a><b>.</b> As cancer develops, the most aggressive cell becomes the dominant cell of the tumor (<a href="ch20_reader_1.xhtml#data-uuid-a8102f7be4c54d3f9e16d4d3b84b1e97" class="link-inline">Fig. 20.2</a>).</p>
        <figure id="data-uuid-a8102f7be4c54d3f9e16d4d3b84b1e97" data-uuid="a8102f7be4c54d3f9e16d4d3b84b1e97">
            <img src="../../img/chapter20/ch20_figure_text_02.png" id="data-uuid-634e8111784f4629919a393167ec2d35" data-uuid="634e8111784f4629919a393167ec2d35" class="text-image ch20_figure_text_02" alt="" />
            <figcaption>
                <span class="figure-number">
                    <span class="figure-designation">Figure</span>
                    <span class="figure-enumeration">20.2</span>
                </span>
                <span class="caption-title">Progression from a single mutation to a tumor.</span>
                <span class="caption-body"><b>a.</b> One cell (dark pink) in a tissue mutates. <b>b.</b> This mutated cell divides repeatedly and a cell (brown) with two mutations appears. <b>c.</b> A tumor forms and a cell with three mutations (purple) appears. <b>d.</b> This cell (purple), which takes over the tumor, can invade underlying tissue. <b>e.</b> Tumor cells invade lymphatic and blood vessels. <b>f.</b> A new tumor forms at a distant location.</span>
            </figcaption>
        </figure>
        <h3 id="data-uuid-f83a3d01102c44d4a09d8cd2ada30fe8" data-uuid="f83a3d01102c44d4a09d8cd2ada30fe8">Cancer Cells Disregard Growth Factors</h3>
        <p id="data-uuid-896c38ec24f3416698ac6d0f58b8a039" data-uuid="896c38ec24f3416698ac6d0f58b8a039">Chemical signals between cells tell them whether or not they should be dividing. These chemical signals, called growth factors, are of two types: stimulatory growth factors and inhibitory growth factors. Cancer cells keep on dividing even when stimulatory growth factors are absent, and they do not respond to inhibitory growth factors.</p>
        <h3 id="data-uuid-7897f587950b418b86efba946a9466dd" data-uuid="7897f587950b418b86efba946a9466dd">Cancer Cells Gradually Become Abnormal</h3>
        <p id="data-uuid-9316401dd3aa407caba5565848f1abf8" data-uuid="9316401dd3aa407caba5565848f1abf8"><a href="ch20_reader_1.xhtml#data-uuid-a8102f7be4c54d3f9e16d4d3b84b1e97" class="link-inline">Figure 20.2</a> illustrates that <a href="../glossary.xhtml#key-carcinogenesis"><dfn title="carcinogenesis">carcinogenesis</dfn></a><b>,</b> the development of cancer, is a multistage process that can be divided into these three phases:</p>
        <ul id="data-uuid-c8daa0291adf46978c5af6544b8f5fa5" data-uuid="c8daa0291adf46978c5af6544b8f5fa5" class="list-second-line-indent">
            <li id="data-uuid-c148b24c7cea4871a302371092e0c770" data-uuid="c148b24c7cea4871a302371092e0c770">
                <p id="data-uuid-eacd0415c105451eb3e1818b023c1916" data-uuid="eacd0415c105451eb3e1818b023c1916"><i>Initiation:</i> A single cell undergoes a mutation that causes it to begin to divide repeatedly (<a href="ch20_reader_1.xhtml#data-uuid-a8102f7be4c54d3f9e16d4d3b84b1e97" class="link-inline">Fig. 20.2<i>a</i></a>).</p>
            </li>
            <li id="data-uuid-250820a4392348a5b8a044ffbcbd1ed5" data-uuid="250820a4392348a5b8a044ffbcbd1ed5">
                <p id="data-uuid-48ba0be06fa84e2b9b15eb2f12628f0a" data-uuid="48ba0be06fa84e2b9b15eb2f12628f0a"><i>Promotion:</i> A tumor develops, and the tumor cells continue to divide. As they divide, they undergo mutations (<a href="ch20_reader_1.xhtml#data-uuid-a8102f7be4c54d3f9e16d4d3b84b1e97" class="link-inline">Fig. 20.2<i>b, c</i></a>).</p>
            </li>
            <li id="data-uuid-1d4813dd1952471dbfa8f08b187e6c3a" data-uuid="1d4813dd1952471dbfa8f08b187e6c3a">
                <p id="data-uuid-92a2d808c4244256b42c4f9aaf9f8ac0" data-uuid="92a2d808c4244256b42c4f9aaf9f8ac0"><i>Progression:</i> One cell undergoes a mutation that gives it a selective advantage over the other cells (<a href="ch20_reader_1.xhtml#data-uuid-a8102f7be4c54d3f9e16d4d3b84b1e97" class="link-inline">Fig. 20.2<i>c</i></a>). This process is repeated several times; eventually, there is a cell that has the ability to invade surrounding tissues (<a href="ch20_reader_1.xhtml#data-uuid-a8102f7be4c54d3f9e16d4d3b84b1e97" class="link-inline">Fig. 20.2<i>d, e</i></a>).</p>
            </li>
        </ul>
        <h3 id="data-uuid-0b6c7d3a69574aa986bb008ee54c2db6" data-uuid="0b6c7d3a69574aa986bb008ee54c2db6">Cancer Cells Undergo Angiogenesis and Metastasis</h3>
        <p id="data-uuid-6a911b5675574ca5899fcb44729f1e71" data-uuid="6a911b5675574ca5899fcb44729f1e71">To grow larger than about a billion cells (about the size of a pea), a tumor must have a well-developed capillary network to bring it nutrients and oxygen. <a href="../glossary.xhtml#key-angiogenesis"><dfn title="angiogenesis">Angiogenesis</dfn></a> is the formation of new blood vessels. The low oxygen content in the middle of a tumor may turn on genes coding for angiogenic growth factors that diffuse into the nearby tissues and cause new vessels to form.</p>
        <p id="data-uuid-0f2a29ebc934460f8247146bd2239163" data-uuid="0f2a29ebc934460f8247146bd2239163">Due to mutations, cancer cells tend to be motile. They have a disorganized internal cytoskeleton and lack intact actin filament bundles. To metastasize, cancer cells must make their way across the basement membrane and invade a blood vessel or lymphatic vessel. Invasive cancer cells are abnormally shaped (see <a href="ch20_reader_1.xhtml#data-uuid-a11e44df12b446ed9650f1aa251c7167" class="link-inline">Fig. 20.1<i>c</i></a>) and don’t look at all like normal cells nearby. Cancer cells produce proteinase enzymes that degrade the basement membrane and allow them to invade underlying tissues. Malignancy occurs when cancer cells are found in nearby lymph nodes. When these cells begin new tumors far from the primary tumor, <a href="../glossary.xhtml#key-metastasis"><dfn title="metastasis">metastasis</dfn></a> has occurred (<a href="ch20_reader_1.xhtml#data-uuid-a8102f7be4c54d3f9e16d4d3b84b1e97" class="link-inline">Fig. 20.2<i>f</i></a>). Not many cancer cells achieve this ability (maybe 1 in 10,000), but those that successfully metastasize to various parts of the body lower the prognosis (the predicted outcome of the disease) for recovery.</p>
        <h2 id="data-uuid-70e141d0e9c74fe0af8d9f556298446e" data-uuid="70e141d0e9c74fe0af8d9f556298446e">Cancer Results from Gene Mutation</h2>
        <figure id="data-uuid-5ecd9d822e0540f6b7478f3fe423173d" data-uuid="5ecd9d822e0540f6b7478f3fe423173d" class="right-icon">
            <img src="../../img/chapter20/ch20_icon02.png" id="data-uuid-b4ebb76f541b4fd88a1255bd01cf0edc" data-uuid="b4ebb76f541b4fd88a1255bd01cf0edc" />
        </figure>
        <p id="data-uuid-22edb8c1f01f40daac23c932415c2216" data-uuid="22edb8c1f01f40daac23c932415c2216">Recall that the cell cycle consists of interphase, followed by mitosis. <a href="../glossary.xhtml#key-checkpoint"><dfn title="checkpoint">Checkpoints</dfn></a> (see <a href="../chapter19/ch19_reader_2.xhtml#data-uuid-26fe7890c0fc49c597e578711025b052" class="link-inline">Fig. 19.3</a>) in the cell cycle monitor the condition of the cell and regulate its ability to divide. Normally, a protein called <a href="../glossary.xhtml#key-cyclin"><dfn title="cyclin">cyclin</dfn></a> directs the movement of a cell through the cell cycle. At each checkpoint specific factors, such as DNA damage, are assessed by checkpoint proteins. However, mutations in these checkpoint proteins cause the cell to lose control of the cell cycle, resulting in cancer. The two classes of checkpoint proteins are as follows:</p>
        <ol id="data-uuid-b44bbeb94f424456b72b119ab76900b6" data-uuid="b44bbeb94f424456b72b119ab76900b6" class="list-bold">
            <li id="data-uuid-053befd2fad94cdd995e272367fe7f1d" data-uuid="053befd2fad94cdd995e272367fe7f1d">
                <p id="data-uuid-23690f4d24e74f4684bf53bc8666d1bf" data-uuid="23690f4d24e74f4684bf53bc8666d1bf"> <a href="../glossary.xhtml#key-proto-oncogene"><dfn title="proto-oncogene">Proto-oncogenes</dfn></a> code for proteins that promote the cell cycle and prevent apoptosis. They are often likened to the gas pedal of a car, because they cause acceleration of the cell cycle.</p>
            </li>
            <li id="data-uuid-9d9891eacc8841bd8f71216eed0daa54" data-uuid="9d9891eacc8841bd8f71216eed0daa54">
                <p id="data-uuid-680c972e7300417e910749b65a723388" data-uuid="680c972e7300417e910749b65a723388"> <a href="../glossary.xhtml#key-tumor-suppressor-gene"><dfn title="tumor suppressor gene">Tumor suppressor genes</dfn></a> code for proteins that inhibit the cell cycle and promote apoptosis. They are often likened to the brakes of a car, because they inhibit acceleration.</p>
            </li>
        </ol>
        <h3 id="data-uuid-9ceb0eb3d876452b8b38ddef098f4c62" data-uuid="9ceb0eb3d876452b8b38ddef098f4c62">Proto-Oncogenes Become Oncogenes</h3>
        <p id="data-uuid-75e54383ea9144278b154f9ab9766f24" data-uuid="75e54383ea9144278b154f9ab9766f24">When proto-oncogenes mutate, they become cancer-causing genes called <a href="../glossary.xhtml#key-oncogene"><dfn title="oncogene">oncogenes</dfn></a><b>.</b> These mutations can be called “gain-of-function,” or dominant, mutations, because overexpression is the result (<a href="ch20_reader_1.xhtml#data-uuid-fb2d67edca784355b99b5bd8e1588dbc" class="link-inline">Fig. 20.3</a>). Even though we possess two copies of each proto-oncogene, only one must be mutated to lose control of the cell cycle. In general, whatever a proto-oncogene does, an oncogene does it better.</p>
        <figure id="data-uuid-fb2d67edca784355b99b5bd8e1588dbc" data-uuid="fb2d67edca784355b99b5bd8e1588dbc">
            <img src="../../img/chapter20/figure203.png" id="data-uuid-3d805265fd0742a0be288f66b247261a" data-uuid="3d805265fd0742a0be288f66b247261a" class="text-image ch20_figure_text_03" alt="" />
            <figcaption>
                <span class="figure-number">
                    <span class="figure-designation">Figure</span>
                    <span class="figure-enumeration">20.3</span>
                </span>
                <span class="caption-title">Mutations in proto-oncogenes produce oncogenes that stimulate the cell cycle.</span>
                <span class="caption-body">Normally, proto-oncogenes stimulate cell division but are typically turned off in differentiated cells. A mutation may convert a proto-oncogene to an oncogene, which then produces a protein that overstimulates the cell cycle. <img src="../../assets/img/tutorial_proto-oncogenes.png" id="data-uuid-a963938b2c2a409db918d031d2dd5dc0" data-uuid="a963938b2c2a409db918d031d2dd5dc0" class="figure-icon inline" /></span>
            </figcaption>
        </figure>
        <p id="data-uuid-ae89025bdb374730af11e6c09c69b255" data-uuid="ae89025bdb374730af11e6c09c69b255">A <a href="../glossary.xhtml#key-growth-factor"><dfn title="growth factor">growth factor</dfn></a> is a signal that activates a cell signaling pathway, resulting in cell division. Some proto-oncogenes code for a growth factor or for a receptor protein that receives a growth factor. When these proto-oncogenes become oncogenes, receptor proteins are easy to activate and may even be stimulated by a growth factor produced by the receiving cell. Several proto-oncogenes code for Ras proteins that promote mitosis by activating cyclin. <i>Ras</i> oncogenes are typically found in many types of cancers. <i>Cyclin D</i> is a proto-oncogene that codes for cyclin directly. When this gene becomes an oncogene, cyclin is readily available all the time.</p>
        <h3 id="data-uuid-ffe44b57603e4a3095f2db97a9e69a7d" data-uuid="ffe44b57603e4a3095f2db97a9e69a7d">Tumor Suppressor Genes Become Inactive</h3>
        <figure id="data-uuid-f4e7ecfee6724fd6a2ce1c9640fcf86a" data-uuid="f4e7ecfee6724fd6a2ce1c9640fcf86a" class="right-icon">
            <img src="../../img/chapter20/ch20_icon03.png" id="data-uuid-2d6a9886358447d0b91f08f757a0d5ca" data-uuid="2d6a9886358447d0b91f08f757a0d5ca" />
        </figure>
        <p id="data-uuid-093b620925ac43d487ddec0215d3d867" data-uuid="093b620925ac43d487ddec0215d3d867">When tumor suppressor genes mutate, their products no longer inhibit the cell cycle or promote apoptosis. Therefore, these mutations can be called “loss-of-function,” or recessive, mutations (<a href="ch20_reader_1.xhtml#data-uuid-57d065729fff43d2bc848ad9379bbbcf" class="link-inline">Fig. 20.4</a>). Unlike proto-oncogenes, both copies of the tumor suppressor gene in the cell must be mutated to lose cell cycle control.</p>
        <figure id="data-uuid-57d065729fff43d2bc848ad9379bbbcf" data-uuid="57d065729fff43d2bc848ad9379bbbcf">
            <img src="../../img/chapter20/figure204.png" id="data-uuid-a03bca990e6f46a5ab2ce58d633e6640" data-uuid="a03bca990e6f46a5ab2ce58d633e6640" class="text-image ch20_figure_text_04" alt="" />
            <figcaption>
                <span class="figure-number">
                    <span class="figure-designation">Figure</span>
                    <span class="figure-enumeration">20.4</span>
                </span>
                <span class="caption-title">Mutations in tumor suppressor genes cause a loss of cell cycle control.</span>
                <span class="caption-body">Normally, tumor suppressor genes code for a protein that inhibits the cell cycle. If mutations occur, the resulting protein loses the function of controlling the cell cycle. <img src="../../assets/img/tutorial_tumor_suppressor_genes.png" id="data-uuid-ccd067da2b6e40928e229618040a180a" data-uuid="ccd067da2b6e40928e229618040a180a" class="figure-icon inline" /></span>
            </figcaption>
        </figure>
        <p id="data-uuid-b5eecf1bcea24166afa12751053df2db" data-uuid="b5eecf1bcea24166afa12751053df2db">Mutation of the tumor suppressor gene <i>Bax</i> is a good example. Its product, the protein Bax, promotes apoptosis. When <i>Bax</i> mutates, Bax protein is not present and apoptosis is less likely to occur. The <i>Bax</i> gene contains a line of eight consecutive G bases in its DNA (see <a href="../chapter02/ch02_reader_0.xhtml" class="link-inline">Chapter 2</a>). When the same base molecules are lined up in this fashion, the gene is more likely to be subject to mutation.</p>
        <p id="data-uuid-e6fd2b41e2594dd39b02e469d947a99c" data-uuid="e6fd2b41e2594dd39b02e469d947a99c">Another tumor suppressor protein, p53, activates DNA repair enzymes. At the same time, p53 turns on genes that stop the cell cycle from proceeding. If repair is impossible, the p53 protein promotes apoptosis. Apoptosis is an important way for carcinogenesis to be prevented. Many tumors are lacking in p53 activity.</p>
        <p id="data-uuid-27c3b3d187db46abbd06b4a9d2155a6e" data-uuid="27c3b3d187db46abbd06b4a9d2155a6e">The <i>BRCA1</i> gene codes for another DNA repair enzyme, one that is responsible for fixing breaks in the DNA molecule. In fact, it works very closely with the p53 protein. <i>BRCA1</i> mutations prevent the body from recognizing DNA damage, allowing the cells to progress through the cell cycle unchecked. <i>BRCA1</i> mutations are associated with a number of cancers, including breast cancer (see the <a href="../chapter19/ch19_reader_0.xhtml" class="link-inline">Chapter 19</a>opener).</p>
        <h2 id="data-uuid-a356309f44ee49bf93dc44ff0eaea94c" data-uuid="a356309f44ee49bf93dc44ff0eaea94c">Types of Cancer</h2>
        <p id="data-uuid-b24fe812580d441aa6bb3c68f45e2218" data-uuid="b24fe812580d441aa6bb3c68f45e2218">Statistics indicate that one in three Americans will deal with cancer in their lifetime. Therefore, this is a topic of considerable importance to the health and well-being of every individual. <a href="../glossary.xhtml#key-oncology"><dfn title="oncology">Oncology</dfn></a> is the study of cancer. A medical specialist in cancer is, therefore, known as an <i>oncologist.</i> The patient’s prognosis (probable outcome) depends on (1) whether the tumor has invaded surrounding tissues and (2) whether there are metastatic tumors in distant parts of the body.</p>
        <p id="data-uuid-775dc8257c99432395400526ce8f55d7" data-uuid="775dc8257c99432395400526ce8f55d7">Tumors are classified according to their place of origin. <a href="../glossary.xhtml#key-carcinoma"><dfn title="carcinoma">Carcinomas</dfn></a> are cancers of the epithelial tissues, and adenocarcinomas are cancers of glandular epithelial cells. Carcinomas include cancer of the skin, breast, liver, pancreas, intestines, lung, prostate, and thyroid. <a href="../glossary.xhtml#key-sarcoma"><dfn title="sarcoma">Sarcomas</dfn></a> are cancers that arise in muscles and connective tissue, such as bone and fibrous connective tissue. <a href="../glossary.xhtml#key-leukemia"><dfn title="leukemia">Leukemias</dfn></a> are cancers of the blood, and <a href="../glossary.xhtml#key-lymphoma"><dfn title="lymphoma">lymphomas</dfn></a> are cancers of lymphoid tissue. A blastoma is a cancer composed of immature cells. Recall that the embryo is formed from three primary germ layers: ectoderm, mesoderm, and endoderm (see <a href="../chapter18/ch18_reader_0.xhtml" class="link-inline">Chapter 18</a>). Each blastoma cell resembles the cells in its original primary germ layer. For example, a nephroblastoma (see the <a href="ch20_reader_0.xhtml#data-uuid-ab8302cedbf147e79a9d1f193e96c292" class="link-inline">chapter opener</a>) has cells similar to mesoderm cells, because the kidney grows from mesoderm.</p>
        <h3 id="data-uuid-883bdcc189aa43e9b294ae4f1682d0e7" data-uuid="883bdcc189aa43e9b294ae4f1682d0e7">Common Cancers</h3>
        <p id="data-uuid-82c7026c985b4373bc8defb7af6d23a8" data-uuid="82c7026c985b4373bc8defb7af6d23a8">Cancer occurs in all parts of the body, but some organs are more susceptible than others (<a href="ch20_reader_1.xhtml#data-uuid-dc56baf31db348d4a5ddccd17d8c85ac" class="link-inline">Fig. 20.5</a>). In the respiratory system, lung cancer is the most common type. Overall, this is one of the most common types of cancer, and smoking is known to increase a person’s risk for this disease. Smoking also increases the risk for cancer in the oral cavity.</p>
        <figure id="data-uuid-dc56baf31db348d4a5ddccd17d8c85ac" data-uuid="dc56baf31db348d4a5ddccd17d8c85ac">
            <img src="../../img/chapter20/cancer_stats.png" id="data-uuid-bfff84abd3454e4e84835273cef284dd" data-uuid="bfff84abd3454e4e84835273cef284dd" class="text-image ch20_figure_text_05" alt="" />
            <figcaption>
                <span class="figure-number">
                    <span class="figure-designation">Figure</span>
                    <span class="figure-enumeration">20.5</span>
                </span>
                <span class="caption-title">Estimated cases of cancer and cancer deaths in the United States.</span>
                <span class="caption-body"><b>a.</b> Estimated new cancer cases in 2014 by sex and location. <b>b.</b> Estimated deaths from cancer in 2014 by sex and location.</span>
                <span class="caption-citation">Adapted with the permission of the American Cancer Society, Inc. All rights reserved.</span>
            </figcaption>
        </figure>
        <p id="data-uuid-85c86919124948d0a61ba4db1565ef8a" data-uuid="85c86919124948d0a61ba4db1565ef8a">In the digestive system, colorectal (colon/rectum) cancer is another common form of cancer. Other cancers of the digestive system include those of the pancreas, stomach, esophagus, and other organs. In the cardiovascular system, cancers include leukemia and plasma cell tumors. In the lymphatic system, cancers are classified as either Hodgkin or non-Hodgkin lymphoma. Hodgkin lymphomas develop from mutated B cells. Non-Hodgkin lymphomas can arise from B cells or T cells. Thyroid cancer is the most common type of tumor in the endocrine system, whereas brain and spinal tumors are found in the central nervous system.</p>
        <p id="data-uuid-713a943ce15244408d5c9ed3122cc559" data-uuid="713a943ce15244408d5c9ed3122cc559">Breast cancer is one of the most common types of cancer. Although predominantly found in women, occasionally it also occurs in men. Cancers of the cervix, ovaries, and other reproductive structures also occur in women. In males, prostate cancer is one of the most common cancers. Other cancers of the male reproductive system include cancer of the testis and the penis. Bladder and kidney cancers are associated with the urinary system. Skin cancers include melanoma and basal and squamous cell carcinomas.</p>
        <section id="data-uuid-d19616d70d6b4544b1856c905cc72c4f" data-uuid="d19616d70d6b4544b1856c905cc72c4f" class="sidenote sidenote-application">
            <h4 id="data-uuid-1304fc6c4d904530917e88e324c04099" data-uuid="1304fc6c4d904530917e88e324c04099">Science in Your life</h4>
            <h5 id="data-uuid-aa178e2d357844dea49a5d7fb4a0c576" data-uuid="aa178e2d357844dea49a5d7fb4a0c576"></h5>
            <h5 id="data-uuid-fc71e45e6ace4ddc90b7fead0e4188c9" data-uuid="fc71e45e6ace4ddc90b7fead0e4188c9">How does cancer cause death?</h5>
            <p id="data-uuid-242588f60fcc42c38711a774b7d20ba1" data-uuid="242588f60fcc42c38711a774b7d20ba1">Often, cancer causes death by interfering with the ability of the body to maintain homeostasis. For example, bone cancer may interfere with calcium homeostasis or the body’s ability to produce red blood cells. The liver and pancreas play an important role in homeostasis, and thus cancers of these organs often cause death by altering the levels of important chemicals (hormones, nutrients) in the blood. Sometimes, a growing tumor blocks an important pathway in the body, such as the lungs, the digestive tract, or an artery. In other cases, the tumor produces chemicals (metabolites) that are toxic to a certain group of tissues.</p>
            <p id="data-uuid-b0ce02e41e334e9281134a235ea9d6f3" data-uuid="b0ce02e41e334e9281134a235ea9d6f3"></p>
        </section>
        <p id="data-uuid-bfcca7fe3e484798913fd0b25875b028" data-uuid="bfcca7fe3e484798913fd0b25875b028"><br />
        </p>
        <section id="data-uuid-85fc9f481edd4715a0a3fc9ce4fe9224" data-uuid="85fc9f481edd4715a0a3fc9ce4fe9224" class="sidenote sidenote-check">
            <h4 id="data-uuid-075eea45e5bb4550b38d85ef4f92e899" data-uuid="075eea45e5bb4550b38d85ef4f92e899">Check Your Progress 20.1</h4>
            <ol id="data-uuid-0096d49e482a40f4bd68eea24afec759" data-uuid="0096d49e482a40f4bd68eea24afec759" class="list-no-style custom-list">
                <li id="data-uuid-acce778f43ec4b23b1333593d01569a8" data-uuid="acce778f43ec4b23b1333593d01569a8">
                    <p id="data-uuid-33171b1479834e058a7ee86c01513536" data-uuid="33171b1479834e058a7ee86c01513536"><img src="../../assets/img/icon4.png" id="data-uuid-46ed4df38177479e894ca72edf73cbed" data-uuid="46ed4df38177479e894ca72edf73cbed" class="icon-list inline" />List the characteristics of cancer cells that allow them to grow uncontrollably.</p>
                </li>
                <li id="data-uuid-382e13a355214c7daee00568a7cdde6e" data-uuid="382e13a355214c7daee00568a7cdde6e">
                    <p id="data-uuid-e44ad7a7d56549dc9251680a6f27aee3" data-uuid="e44ad7a7d56549dc9251680a6f27aee3"><img src="../../assets/img/icon5.png" id="data-uuid-58013fec7b25482cb10402d29d82355e" data-uuid="58013fec7b25482cb10402d29d82355e" class="icon-list inline" />Describe how mutations in tumor suppressor genes and proto-oncogenes have opposite effects on the cell cycle.</p>
                </li>
                <li id="data-uuid-01c23f7146904bb2aaac33a37585fa0f" data-uuid="01c23f7146904bb2aaac33a37585fa0f">
                    <p id="data-uuid-3de48af568c1467e8e47d5ed8f77361b" data-uuid="3de48af568c1467e8e47d5ed8f77361b"><img src="../../assets/img/icon6.png" id="data-uuid-eab42cdab78643fdbd77f46e98e8d109" data-uuid="eab42cdab78643fdbd77f46e98e8d109" class="icon-list inline" />Summarize some of the more common types of cancer.</p>
                </li>
            </ol>
        </section>
        <section id="data-uuid-2bb2dc3f1ca14bdf8d25d06a68f5a0da" data-uuid="2bb2dc3f1ca14bdf8d25d06a68f5a0da" class="sidenote sidenote-connecting">
            <h4 id="data-uuid-9e0fc9f222c14700b40763aebe1cb33d" data-uuid="9e0fc9f222c14700b40763aebe1cb33d">Connecting the Concepts</h4>
            <ul id="data-uuid-07f0642fe12542c999f6dec6c265d105" data-uuid="07f0642fe12542c999f6dec6c265d105" class="list-no-style list-no-indent">
                <li id="data-uuid-e0a3f9abb3df4601848fa15cee814d8b" data-uuid="e0a3f9abb3df4601848fa15cee814d8b">
                    <p id="data-uuid-3f5b11eff38d40538b1fede46d50a6b6" data-uuid="3f5b11eff38d40538b1fede46d50a6b6">For more information on the topics in this section, refer to the following discussions:</p>
                </li>
                <li id="data-uuid-427dfdee64424ed3a32a0fdbaf9f0878" data-uuid="427dfdee64424ed3a32a0fdbaf9f0878">
                    <p id="data-uuid-616df179be064801a53a44e7546487ca" data-uuid="616df179be064801a53a44e7546487ca"><a href="../chapter19/ch19_reader_2.xhtml#data-uuid-542d960d30524a9a82e2c27c778c5e5b" class="link-inline">Section 19.2</a> describes the role of the checkpoints of the cell cycle.</p>
                </li>
                <li id="data-uuid-affa7386b32647db9f5b845e6654b570" data-uuid="affa7386b32647db9f5b845e6654b570">
                    <p id="data-uuid-adca5522e54d4624afdd3a8724536567" data-uuid="adca5522e54d4624afdd3a8724536567"><a href="../chapter22/ch22_reader_2.xhtml#data-uuid-08c034203f1343be9527a0c4338f56b4" class="link-inline">Section 22.2</a> describes how the information in a gene is expressed to form a protein.</p>
                </li>
            </ul>
        </section>
        <footer id="data-uuid-6dc5898634894808a5e3825ac44e9daf" data-uuid="6dc5898634894808a5e3825ac44e9daf">
        </footer>
    </body>
</html>